Cargando…
Purinergic Signaling in the Hallmarks of Cancer
Cancer is a complex expression of an altered state of cellular differentiation associated with severe clinical repercussions. The effort to characterize this pathological entity to understand its underlying mechanisms and visualize potential therapeutic strategies has been constant. In this context,...
Autores principales: | Campos-Contreras, Anaí del Rocío, Díaz-Muñoz, Mauricio, Vázquez-Cuevas, Francisco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407645/ https://www.ncbi.nlm.nih.gov/pubmed/32635260 http://dx.doi.org/10.3390/cells9071612 |
Ejemplares similares
-
Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells
por: Campos-Contreras, Anaí del Rocío, et al.
Publicado: (2022) -
Purinergic Activation of Store-Operated Calcium Entry (SOCE) Regulates Cell Migration in Metastatic Ovarian Cancer Cells
por: Mata-Martínez, Esperanza, et al.
Publicado: (2023) -
Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl(4)-Treated Fibrotic Mice
por: Velázquez-Miranda, Erandi, et al.
Publicado: (2020) -
Purinergic Signalling in the Cochlea
por: Vlajkovic, Srdjan M., et al.
Publicado: (2022) -
Colorectal Cancer and Purinergic Signalling: An Overview
por: Roliano, Gabriela Gonçalves, et al.
Publicado: (2022)